{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:58:09Z","timestamp":1790546289607,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T00:00:00Z","timestamp":1724630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37012","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T05:16:01Z","timestamp":1724735761000},"page":"e37012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["ADCY5 act as a putative tumor suppressor in glioblastoma: An integrated analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Wang","family":"Can","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Deqing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Honglei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xiaoyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Jiangdong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37012_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","article-title":"Epigenetics of glioblastoma multiforme: from molecular mechanisms to therapeutic approaches","volume":"83","author":"Uddin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.heliyon.2024.e37012_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1180943","article-title":"Advances in nanotechnology for the treatment of GBM","volume":"17","author":"Wei","year":"2023","journal-title":"Front. Neurosci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37012_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21037\/cco-22-92","article-title":"Proton radiotherapy for glioma and glioblastoma","volume":"11","author":"Goff","year":"2022","journal-title":"Chin. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37012_bib4","doi-asserted-by":"crossref","first-page":"11864","DOI":"10.18632\/aging.103357","article-title":"Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.heliyon.2024.e37012_bib5","article-title":"Targeting adenylate cyclase family: new concept of targeted cancer therapy","volume":"12","author":"Guo","year":"2022","journal-title":"Front. Oncol."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e37012_bib6","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3390\/cells11132020","article-title":"cAMP signaling in cancer: a PKA-CREB and EPAC-centric approach","volume":"11","author":"Ahmed","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.heliyon.2024.e37012_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1024423","article-title":"The cAMP-signaling cancers: clinically-divergent disorders with a common central pathway","volume":"13","author":"Bolger","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37012_bib8","first-page":"54","article-title":"Genetic variants in GCKR, GIPR, ADCY5 and VPS13C and the risk of severe sulfonylurea-induced hypoglycaemia in patients with type 2 diabetes, Experimental and clinical endocrinology & diabetes : official journal","volume":"121","author":"Holstein","year":"2013","journal-title":"German Society of Endocrinology [and] German Diabetes Association"},{"issue":"17","key":"10.1016\/j.heliyon.2024.e37012_bib9","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.3346\/jkms.2022.37.e139","article-title":"Origin of lee quedae's knowledge of artistic anatomy","volume":"37","author":"Hwang","year":"2022","journal-title":"J. Korean Med. Sci."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37012_bib10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.apsb.2021.10.007","article-title":"Genome-wide analysis identify novel germline genetic variations in ADCY1 influencing platinum-based chemotherapy response in non-small cell lung cancer","volume":"12","author":"Mao","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.heliyon.2024.e37012_bib11","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.2147\/IJGM.S330680","article-title":"A pan-cancer analysis of the prognostic value and expression of adenylate cyclase 7 (ADCY7) in human tumors","volume":"14","author":"Zeng","year":"2021","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e37012_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3298","article-title":"Assessment of ADCY9 polymorphisms and colorectal cancer risk in the Chinese Han population","volume":"23","author":"Li","year":"2021","journal-title":"J. Gene Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37012_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41419-020-2381-8","article-title":"MOB2 suppresses GBM cell migration and invasion via regulation of FAK\/Akt and cAMP\/PKA signaling","volume":"11","author":"Jiang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37012_bib14","first-page":"1","article-title":"TRIP13 promotes the cell proliferation, migration and invasion of glioblastoma through the FBXW7\/c-MYC axis","volume":"121","author":"Zhang","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"27","key":"10.1016\/j.heliyon.2024.e37012_bib15","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1038\/s41388-020-1348-7","article-title":"GBP2 enhances glioblastoma invasion through Stat3\/fibronectin pathway","volume":"39","author":"Yu","year":"2020","journal-title":"Oncogene"},{"issue":"3\/4","key":"10.1016\/j.heliyon.2024.e37012_bib16","first-page":"34","article-title":"Tetrandrine inhibits human brain glioblastoma multiforme GBM 8401 cancer cell migration and invasion in vitro","author":"Jiang","year":"2019","journal-title":"Environ. Toxicol."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2024.e37012_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000331670","article-title":"Functional enrichment analysis with structural variants: pitfalls and strategies","volume":"135","author":"Webber","year":"2011","journal-title":"Cytogenet. Genome Res."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37012_bib18","first-page":"420","article-title":"Transcriptional E2F1\/2\/3\/6 as potential prognostic biomarkers in cutaneous melanoma","volume":"13","author":"Li","year":"2021","journal-title":"American Journal of Translational Research"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37012_bib20","first-page":"1137","article-title":"The significance of MGMT methylation in Glioblastoma Multiforme prognosis","volume":"68","author":"Rao","year":"2018","journal-title":"JPMA. The Journal of the Pakistan Medical Association"},{"key":"10.1016\/j.heliyon.2024.e37012_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1144184","article-title":"The function of histone methylation and acetylation regulators in GBM pathophysiology","volume":"13","author":"McCornack","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37012_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-014-1701-1","article-title":"Prognosis of glioblastoma with faint MGMT methylation-specific PCR product","volume":"122","author":"Hsu","year":"2015","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.heliyon.2024.e37012_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.944452","article-title":"Advances in immunotherapy for glioblastoma multiforme","volume":"13","author":"Mahmoud","year":"2022","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.heliyon.2024.e37012_bib24","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.3390\/cancers14215377","article-title":"New directions in the therapy of glioblastoma","volume":"14","author":"Szklener","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.heliyon.2024.e37012_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.983097","article-title":"Lrig1 regulates the balance between proliferation and quiescence in glioblastoma stem cells","volume":"10","author":"Ferguson","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e37012_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3892\/ol.2022.13327","article-title":"Type 2 diabetes is more closely associated with risk of colorectal cancer based on elevated DNA methylation levels of ADCY5","volume":"24","author":"Wei","year":"2022","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e37012_bib27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cmet.2021.01.001","article-title":"A regulatory variant at 3q21.1 confers an increased pleiotropic risk for hyperglycemia and altered bone mineral density","volume":"33","author":"Sinnott-Armstrong","year":"2021","journal-title":"Cell Metab."},{"issue":"23","key":"10.1016\/j.heliyon.2024.e37012_bib28","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1212\/WNL.0000000000002058","article-title":"ADCY5-related dyskinesia: broader spectrum and genotype-phenotype correlations","volume":"85","author":"Chen","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e37012_bib29","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/mds.28495","article-title":"An update on the phenotype, genotype and neurobiology of ADCY5-related disease","volume":"36","author":"Ferrini","year":"2021","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.heliyon.2024.e37012_bib30","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.7150\/thno.55482","article-title":"Endogenous glutamate determines ferroptosis sensitivity via ADCY10-dependent YAP suppression in lung adenocarcinoma","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e37012_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1017\/S0029665118000150","article-title":"The role of DNA methylation in ageing and cancer","volume":"77","author":"Morgan","year":"2018","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.heliyon.2024.e37012_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105937","article-title":"RNA methylation and cancer treatment","volume":"174","author":"Yang","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e37012_bib33","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s004240100607","article-title":"G-protein- and cAMP-dependent L-channel gating modulation: a manyfold system to control calcium entry in neurosecretory cells","volume":"442","author":"Carbone","year":"2001","journal-title":"Pflugers Arch"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e37012_bib34","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00210-019-01650-1","article-title":"cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs","volume":"392","author":"Aktories","year":"2019","journal-title":"Naunyn-Schmiedeberg's archives of pharmacology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e37012_bib35","article-title":"Unique effects of acute aripiprazole treatment on the dopamine D2 receptor downstream cAMP-PKA and akt-gsk3\u03b2 signalling pathways in rats","volume":"10","author":"Bo","year":"2015","journal-title":"PLoS One"},{"issue":"5\u20136","key":"10.1016\/j.heliyon.2024.e37012_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/mrd.23569","article-title":"CD55 is upregulated by cAMP\/PKA\/AKT and modulates human decidualization via Src and ERK pathway and decidualization-related genes","volume":"89","author":"Tang","year":"2022","journal-title":"Mol. Reprod. Dev."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024130435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024130435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:22:37Z","timestamp":1790544157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024130435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024130435"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37012","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADCY5 act as a putative tumor suppressor in glioblastoma: An integrated analysis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37012"}}